Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation JIM 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presenter: Roxana Mehran

February 10, 2017

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

Presentation JIM 2016

Self- Apposing Stents in STEMI:The Stentys Experience

Presenter: Roxana Mehran

February 10, 2016

Presentation Fellows 2015

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Manish A. Parikh, Roxana Mehran

May 15, 2015

Presentation Fellows 2015

Antithrombin Pharmacology for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, David J. Cohen

May 15, 2015

Presentation Fellows 2015

Antiplatelet Therapy for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone

May 15, 2015

Presentation

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Presenter: Roxana Mehran

May 08, 2015

Presentation TCT 2014

Difficult Primary PCI Decisions

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab

September 16, 2014

Presentation TCT 2014

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Presenter: Roxana Mehran, Harvey D. White, Yaling Han

September 15, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Roxana Mehran

September 14, 2014

Presentation TCT 2013

Current Choice of Antiplatelet Therapies in NSTEMI and STEMI

Presenter: Roxana Mehran

October 28, 2013

Presentation TCT 2013

Editorial Comment: Pharmacological Therapy and Hemodynamic Support in the Shock Patient: Does It Matter?

Presenter: Roxana Mehran

October 28, 2013

Presentation TCT 2013

Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial

Presenter: Joe Dizon, Sorin Brener, Akiko Maehara, Bernhard Witzenbichler, Jacek Godlewski, Helen Parise, Jan-Henk Dambrink, Roxana Mehran, C. Michael Gibson, Gregg Stone

January 31, 2013

Presentation TCT 2013

Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY...

Presenter: David Planer, E. Magnus Ohman, Harvey White, Jeffrey Moses, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2013

Low Overall Rates of Angiographically Visible Distal Embolization in INFUSE-AMI: Possible Explanation for Lack of Efficacy of Manual Aspiration Thrombectomy

Presenter: Magdi El-Omar, Sorin Brener, Akiko Maehara, Thomas Scott, Roxana Mehran, Wim Aengevaeren, Dariusz Dudek, Martin Fahy, C. Michael Gibson, Gregg Stone

January 31, 2013

Presentation TCT 2013

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Presenter: Benoit Daneault, Philippe Genereux, Ajay Kirtane, Bernhard Witzenbichler, Giulio Guagliumi, Jean-Michel Paradis, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2013

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Presenter: A. Rene, Philippe Genereux, Michael Ezekowitz, Ajay Kirtane, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2013

Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

Presenter: Akiko Maehara, Gary Mintz, Sorin Brener, Jan-Henk Dambrink, Magdi El-Omar, Anthony Gershlick, Martin Fahy, Roxana Mehran, C. Michael Gibson, Gregg Stone

January 31, 2013

Presentation TCT 2013

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Presenter: Andreas Baumbach, Harold Dauerman, Bernardo Cortese, Martial Hamon, Jayne Prats, Efthymios Deliargyris, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Advertisement

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Optimal Duration of DAPT: Update on DAPT Guidelines

Self- Apposing Stents in STEMI:The Stentys Experience

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antithrombin Pharmacology for the Interventionalist

Antiplatelet Therapy for the Interventionalist

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Difficult Primary PCI Decisions

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

The Data Strongly Support Bivalirudin!

Current Choice of Antiplatelet Therapies in NSTEMI and STEMI

Editorial Comment: Pharmacological Therapy and Hemodynamic Support in the Shock Patient: Does It Matter?

Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial

Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY...

Low Overall Rates of Angiographically Visible Distal Embolization in INFUSE-AMI: Possible Explanation for Lack of Efficacy of Manual Aspiration Thrombectomy

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content